ALA Price sensitive 23 Sep 2025, 9:10 AM

Arovella receives R&D tax rebate of $3.21 million

Arovella Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in